Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for dec- 205 receptor
Most Correlated Studies
- Bone Marrow Dendritic Cells exposed to different antigen delivery systems
- Prostate cancer PC-3 cells overexpressing miR-205, AGO2 bound RNAs
- T-cells with FOXP3 siRNA knockdown and activated with anti-CD2/CD3/CD28 antibodies + IL2
- Effect of IL-17 on human vascular smooth muscle cells
- Splenic B cells from Ptger4-/- mice treated with anti-IgM (Fab')2 fragments and PGE2
Most Relevant Literature
- DEC-205 receptor targeted poly(lactic-co-glycolic acid) nanoparticles containing Eucommia ulmoides p…
- The cryo-EM structure of the endocytic receptor DEC-205.
- Development and characterization of DEC-205 receptor targeted Potentilla anserina L polysaccharide P…
- DEC-205 receptor-mediated long-circling nanoliposome as an antigen and Eucommia ulmoides polysacchar…
- Ex vivo assessment of in vivo DC-targeted antibodies in pre-clinical models.
Most Relevant Clinical Trials
- DCVax Plus Poly ICLC in Healthy Volunteers
- Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
- DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patie…
- A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced …
- DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients …
